Compounds > diosgenin
Page last updated: 2024-08-26

diosgenin and Angiogenesis, Pathologic

diosgenin has been researched along with Angiogenesis, Pathologic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Bai, JX; Chen, YJ; Chou, JY; Fu, XQ; Li, JK; Li, SM; Liu, YX; Niu, XD; Wang, XQ; Wu, JY; Wu, Y; Xu, BW; Yin, CL; Yu, ZL1
Cai, H; Gong, L; Liu, J; Zheng, Z; Zhou, Q1
Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L1
Chen, S; Lei, Y; Liang, Y; Liu, H; Liu, Y; Meng, J; Qian, B; Qiao, K; Sun, T; Wang, H; Xiao, T; Yang, C; Zhang, H; Zhao, J; Zhong, W; Zhou, H; Zong, S1
Gao, YX; Guo, YC; Song, HR1
Bai, P; Huang, Q; Liu, S; Wang, H; Xiao, J; Xiao, X; Yang, F; Yang, K; Yang, M; Zhang, B; Zou, J1
Hu, X; Jiang, L; Qing, Y; Tong, Q; Wu, X; Wu, Y1
Bai, P; Liu, S; Wang, H; Xiao, X; Yang, M; Zhu, H; Zou, J1

Other Studies

8 other study(ies) available for diosgenin and Angiogenesis, Pathologic

ArticleYear
Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin.
    Pharmacological research, 2022, Volume: 175

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Diosgenin; Human Umbilical Vein Endothelial Cells; Humans; Male; Melanoma, Experimental; Mice, Inbred C57BL; Neovascularization, Pathologic; src-Family Kinases; STAT3 Transcription Factor; Tumor Burden

2022
Diosgenin inhibits tumor angiogenesis through regulating GRP78-mediated HIF-1α and VEGF/VEGFR signaling pathways.
    Die Pharmazie, 2019, 11-01, Volume: 74, Issue:11

    Topics: Apoptosis; Diosgenin; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation; Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Phosphorylation; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2019
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
    Cancer science, 2020, Volume: 111, Issue:2

    Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell-Penetrating Peptides; Diosgenin; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Liposomes; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Rats; Xenograft Model Antitumor Assays

2020
Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
    Cell death & disease, 2018, 09-05, Volume: 9, Issue:9

    Topics: Animals; Antigens, CD; Cadherins; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Diosgenin; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Transcription, Genetic; Twist-Related Protein 1

2018
[Effects of dioscornin tablet containing serum on NF-kappaB p65, STAT3, and VEGF mRNA expressions in rats' synovial cell strain RSC-364 induced by IL-17 and TNF-alpha].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2013, Volume: 33, Issue:6

    Topics: Animals; Arthritis, Rheumatoid; Cells, Cultured; Diosgenin; Interleukin-17; Male; Neovascularization, Pathologic; Rats; Rats, Wistar; RNA, Messenger; Serum; Signal Transduction; STAT3 Transcription Factor; Synovial Membrane; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2013
Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
    Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Diosgenin; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Random Allocation; Rats; Rats, Sprague-Dawley; Saponins; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
    Toxicology and applied pharmacology, 2014, Dec-01, Volume: 281, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Diosgenin; Dose-Response Relationship, Drug; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Proto-Oncogene Proteins c-akt; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2

2014
Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Oncology reports, 2015, Volume: 33, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Diosgenin; Electrophoretic Mobility Shift Assay; Female; Heterografts; Humans; Immunohistochemistry; Immunoprecipitation; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Ovarian Neoplasms; Saponins; Signal Transduction

2015